Shares of Amarantus BioSciences Inc. (OTC: AMBS), a development-stage biotechnology company engaged in the discovery and development of therapeutic proteins and biologics for treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases, are marginally lower in trading today.
[...]
Recent Comments